Products used to Treat Hemophilia: Recombinant Factor VIIa
Ulla K.E. Hedner
Abstract
Ulla K.E. Hedner
Abstract
This chapter contains sections titled: Background Mechanism of action of recombinant factor VIIa Clinical experience with recombinant factor VIIa in hemophilia patients with inhibitors Use of recombinant factor VIIa in other bleeding disorders Safety References
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter contains sections titled: Background Mechanism of action of recombinant factor VIIa Clinical experience with recombinant factor VIIa in hemophilia patients with inhibitors Use of recombinant factor VIIa in other bleeding disorders Safety References
Key concepts: Recombinant factor VIIa, Recombinant DNA, Factor VIIa, Medicine, Factor VII, Surgery, Internal medicine, Coagulation